Literature DB >> 24066201

Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction?

Hani Jneid1, Mahboob Alam, Salim S Virani, Biykem Bozkurt.   

Abstract

Myocardial infarction (MI) is a major cause of mortality and morbidity worldwide. Each year, an estimated 785,000 persons will have a new MI in the United States alone, and approximately every minute an American will succumb to one.1 In addition, MI has major psychological and legal implications for patients and the society and is an important outcome measure in research studies. The prevalence of MI provides useful data regarding the burden of coronary artery disease and offers insight into health care planning, policy, and resource allocation. The importance of accurately and reproducibly defining MI is therefore self-evident. The Third Universal Definition of Myocardial Infarction (MI) expert consensus document was published in October 2012 by the global Myocardial Infarction Task Force.2 This landmark document was cosponsored by multiple cardiovascular societies and included both updated definitions and a modified classification of MI that have important clinical, epidemiological, and research implications. We hereby present a critical overview of this important document and summarize its key recommendations.

Entities:  

Keywords:  Third Universal Definition of Myocardial Infarction; acute coronary syndrome; cardiac troponin biomarkers; myocardial infarction; revascularization

Mesh:

Substances:

Year:  2013        PMID: 24066201      PMCID: PMC3782325          DOI: 10.14797/mdcj-9-3-169

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  15 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  L David Hillis; Peter K Smith; Jeffrey L Anderson; John A Bittl; Charles R Bridges; John G Byrne; Joaquin E Cigarroa; Verdi J Disesa; Loren F Hiratzka; Adolph M Hutter; Michael E Jessen; Ellen C Keeley; Stephen J Lahey; Richard A Lange; Martin J London; Michael J Mack; Manesh R Patel; John D Puskas; Joseph F Sabik; Ola Selnes; David M Shahian; Jeffrey C Trost; Michael D Winniford
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

3.  World Health Organization definition of myocardial infarction: 2008-09 revision.

Authors:  Shanthi Mendis; Kristian Thygesen; Kari Kuulasmaa; Simona Giampaoli; Markku Mähönen; Kathleen Ngu Blackett; Liu Lisheng
Journal:  Int J Epidemiol       Date:  2010-10-05       Impact factor: 7.196

4.  Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry.

Authors:  Michael C Kontos; James A de Lemos; Fang-Shu Ou; Stephan D Wiviott; Joanne M Foody; L Kristin Newby; Anita Chen; Matthew T Roe
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

5.  2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

6.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Hugo A Katus; Bertil Lindahl; David A Morrow; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis
Journal:  Circulation       Date:  2012-08-24       Impact factor: 29.690

7.  ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.

Authors:  L Kristin Newby; Robert L Jesse; Joseph D Babb; Robert H Christenson; Thomas M De Fer; George A Diamond; Francis M Fesmire; Stephen A Geraci; Bernard J Gersh; Greg C Larsen; Sanjay Kaul; Charles R McKay; George J Philippides; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2012-11-12       Impact factor: 24.094

8.  Bare metal stent restenosis is not a benign clinical entity.

Authors:  Michael S Chen; Jim M John; Derek P Chew; David S Lee; Stephen G Ellis; Deepak L Bhatt
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

9.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

10.  Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation.

Authors:  Richard F Alcock; Probal Roy; Katrina Adorini; George T Lau; Len Kritharides; Harry C Lowe; David B Brieger; Saul Benedict Freedman
Journal:  Int J Cardiol       Date:  2009-01-07       Impact factor: 4.164

View more
  9 in total

Review 1.  Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population.

Authors:  Kamal Shemisa; Anish Bhatt; Daniel Cheeran; Ian J Neeland
Journal:  Curr Heart Fail Rep       Date:  2017-08

2.  Effects of rhBNP on myocardial fibrosis after myocardial infarction in rats.

Authors:  Zhendong Su; Guoqian Wei; Li Wei; Junyan Liu; Xueqi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 3.  Rivaroxaban: a review of its use in acute coronary syndromes.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

4.  Weak prediction power of the Framingham Risk Score for coronary artery disease in nonagenarians.

Authors:  Josef Yayan
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 5.  The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome.

Authors:  Sanoj Chacko; Sohaib Haseeb; Benedict M Glover; David Wallbridge; Alan Harper
Journal:  Future Sci OA       Date:  2017-10-27

6.  Tanshinone IIA prevents left ventricular remodelling via the TLR4/MyD88/NF-κB signalling pathway in rats with myocardial infarction.

Authors:  Dong-Mei Wu; Yong-Jian Wang; Xin-Rui Han; Xin Wen; Lei Li; Lan Xu; Jun Lu; Yuan-Lin Zheng
Journal:  J Cell Mol Med       Date:  2018-03-10       Impact factor: 5.310

7.  Peiminine inhibits myocardial injury and fibrosis after myocardial infarction in rats by regulating mitogen-activated protein kinase pathway.

Authors:  Peng Chen; Dengming Zhou; Yongsheng Liu; Ping Wang; Weina Wang
Journal:  Korean J Physiol Pharmacol       Date:  2022-03-01       Impact factor: 2.016

8.  Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.

Authors:  Gunter Almer; Kelli L Summers; Bernhard Scheicher; Josef Kellner; Ingeborg Stelzer; Gerd Leitinger; Anna Gries; Ruth Prassl; Andreas Zimmer; Harald Mangge
Journal:  Int J Nanomedicine       Date:  2014-09-03

9.  Cigarette smoking might weaken the prognostic significance of cytochrome P450 2C19*2 polymorphism in acute myocardial infarction patients.

Authors:  Mingyu Zhang; Xiaoxia Liu; Lei Wang; Yan Wang; Li Ju; Jianfei Li
Journal:  J Cell Mol Med       Date:  2016-04-12       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.